Table 1.
Sample characteristics and demographics (N = 515)
| n | % | |
|---|---|---|
| Sex | ||
| Female | 510 | 99.0 |
| Male | 4 | 0.8 |
| Transgender | 1 | 0.2 |
| Age | ||
| < 50 years | 134 | 26.0 |
| 50–64 years | 220 | 42.7 |
| > 65 years | 128 | 24.9 |
| Did not report | 33 | 6.4 |
| Education | ||
| Less than 4-year college degree | 132 | 25.6 |
| 4-year degree | 160 | 31.1 |
| More than 4-year degree | 221 | 42.9 |
| Did not report | 2 | 0.4 |
| Financial status | ||
| Having enough money for special things | 307 | 59.6 |
| Not having enough money for special things | 187 | 36.3 |
| Did not report | 21 | 4.1 |
| Marital status | ||
| Married/Living as married | 369 | 71.4 |
| Not married | 141 | 27.4 |
| Did not report | 5 | 1.0 |
| Children | ||
| No children | 125 | 24.3 |
| At least 1 child (none under 18 living at home) | 280 | 54.4 |
| At least one child under 18 living at home | 110 | 21.4 |
| Metastatic site location | ||
| Single site (not bone) | 174 | 33.8 |
| Single site (bone) | 309 | 60.0 |
| Multiple sites | 32 | 6.2 |
| Current oncologic treatment | ||
| Endocrine therapy only | 70 | 13.6 |
| Chemotherapy only | 62 | 12.0 |
| Targeted therapy or immunotherapy only | 51 | 9.9 |
| Endocrine therapy with immune therapy or targeted therapy | 46 | 8.9 |
| Any other combination treatment with chemotherapy | 87 | 16.9 |
| Any other combination treatment without chemotherapy | 154 | 29.9 |
| No treatment | 33 | 6.4 |
| Did not report | 12 | 2.3 |